2CUR | pdb_00002cur

Solution structure of Skeletal muscle LIM-protein 1

External Resource: Annotation

Domain Annotation: SCOP/SCOPe Classification
Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d2cura1	Small proteins	Glucocorticoid receptor-like (DNA-binding domain)	Glucocorticoid receptor-like (DNA-binding domain)	LIM domain	Four and a half LIM domains protein 1, FHL-1	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d2cura4	Artifacts	Tags	Tags	Tags	C-terminal Tags	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d2cura3	Artifacts	Tags	Tags	Tags	N-terminal Tags	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2 Family	LIM domain	8026936	4003634	SCOP2 (2022-06-29)
A	SCOP2 Family	LIM domain	8026940	4003634	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	Glucocorticoid receptor-like (DNA-binding domain)	8039315	3000068	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	Glucocorticoid receptor-like (DNA-binding domain)	8039319	3000068	SCOP2 (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	LIM	e2curA1	A: few secondary structure elements	X: Glucocorticoid receptor-like	H: LIM domain-like	T: LIM domain-like	F: LIM	ECOD (v294.1)
A	Metallothio	e2curA2	A: a/b three-layered sandwiches	X: EGF-like	H: EGF-related	T: EGF/Laminin	F: Metallothio	ECOD (v294.1)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	2.10.110.10	Mainly Beta	Ribbon	Cysteine Rich Protein	Cysteine Rich Protein	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00412	LIM domain (LIM)	LIM domain	This family represents two copies of the LIM structural domain.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Skeletal muscle LIM-protein 1	protein binding binding transmembrane transporter binding potassium channel regulator activity transporter activator activity channel regulator activity potassium channel activator activity molecular function activator activity ion channel regulator activity molecular function regulator activity channel activator activity transporter regulator activity cation binding transition metal ion binding protein binding binding transmembrane transporter binding potassium channel regulator activity transporter activator activity channel regulator activity potassium channel activator activity molecular function activator activity ion channel regulator activity molecular function regulator activity channel activator activity transporter regulator activity cation binding transition metal ion binding zinc ion binding ion binding metal ion binding small molecule binding	developmental process cellular developmental process cell differentiation cellular process anatomical structure morphogenesis anatomical structure development animal organ development animal organ morphogenesis regulation of cell cycle phase transition regulation of cellular process negative regulation of biological process negative regulation of cell cycle cell cycle phase transition regulation of cell cycle G1/S phase transition developmental process cellular developmental process cell differentiation cellular process anatomical structure morphogenesis anatomical structure development animal organ development animal organ morphogenesis regulation of cell cycle phase transition regulation of cellular process negative regulation of biological process negative regulation of cell cycle cell cycle phase transition regulation of cell cycle G1/S phase transition cell cycle G1/S phase transition mitotic cell cycle negative regulation of mitotic cell cycle regulation of mitotic cell cycle negative regulation of cellular process negative regulation of cell cycle phase transition cell cycle regulation of cell cycle cell cycle process negative regulation of G1/S transition of mitotic cell cycle regulation of biological process negative regulation of mitotic cell cycle phase transition regulation of cell cycle process negative regulation of cell cycle G1/S phase transition biological regulation negative regulation of cell cycle process regulation of mitotic cell cycle phase transition mitotic cell cycle process regulation of G1/S transition of mitotic cell cycle G1/S transition of mitotic cell cycle mitotic cell cycle phase transition regulation of membrane depolarization membrane depolarization regulation of biological quality regulation of atrial cardiac muscle cell membrane depolarization regulation of membrane potential G2/M transition of mitotic cell cycle cell cycle G2/M phase transition regulation of G2/M transition of mitotic cell cycle regulation of cell cycle G2/M phase transition negative regulation of cell cycle G2/M phase transition negative regulation of G2/M transition of mitotic cell cycle muscle structure development muscle organ development regulation of growth regulation of cellular component organization growth negative regulation of cell growth regulation of cell growth cell growth cellular component organization negative regulation of growth cellular component organization or biogenesis regulation of localization positive regulation of cation transmembrane transport regulation of potassium ion transport transport monoatomic ion transmembrane transport positive regulation of biological process potassium ion transmembrane transport regulation of monoatomic ion transmembrane transport metal ion transport monoatomic cation transmembrane transport localization positive regulation of monoatomic ion transport positive regulation of transmembrane transport monoatomic ion transport positive regulation of monoatomic ion transmembrane transport monoatomic cation transport regulation of metal ion transport positive regulation of cellular process regulation of transport regulation of monoatomic ion transport regulation of potassium ion transmembrane transport establishment of localization transmembrane transport positive regulation of potassium ion transport regulation of transmembrane transport positive regulation of transport positive regulation of potassium ion transmembrane transport regulation of monoatomic cation transmembrane transport potassium ion transport	cellular anatomical structure anchoring junction cell junction focal adhesion cell-substrate junction intracellular anatomical structure cytoplasm cytosol cell periphery plasma membrane membrane membrane-bounded organelle intracellular organelle organelle cellular anatomical structure anchoring junction cell junction focal adhesion cell-substrate junction intracellular anatomical structure cytoplasm cytosol cell periphery plasma membrane membrane membrane-bounded organelle intracellular organelle organelle nucleus intracellular membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR056807	FHL1/2/3/5, N-terminal LIM domain	Domain
A	IPR042997	Four and a half LIM domains protein 1	Family
A	IPR001781	Zinc finger, LIM-type	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q13642	myopathy, reducing body, X-linked, early-onset, severe myopathy, reducing body, X-linked, childhood-onset X-linked myopathy with postural muscle atrophy X-linked scapuloperoneal muscular dystrophy Emery-Dreifuss muscular dystrophy Liver Cirrhosis, Experimental X-linked Emery-Dreifuss muscular dystrophy hypertrophic cardiomyopathy ulcerative colitis limb-girdle muscular dystrophy lung cancer malignant ependymoma adrenal cortex carcinoma medulloblastoma atopic eczema myopathy, reducing body, X-linked, early-onset, severe myopathy, reducing body, X-linked, childhood-onset X-linked myopathy with postural muscle atrophy X-linked scapuloperoneal muscular dystrophy Emery-Dreifuss muscular dystrophy Liver Cirrhosis, Experimental X-linked Emery-Dreifuss muscular dystrophy hypertrophic cardiomyopathy ulcerative colitis limb-girdle muscular dystrophy lung cancer malignant ependymoma adrenal cortex carcinoma medulloblastoma atopic eczema muscular dystrophy breast fibroadenoma oligodendroglioma dermatomyositis pancreatic intraductal papillary-mucinous carcinoma Down syndrome psoriasis Sjogren syndrome intellectual disability Uruguay Faciocardiomusculoskeletal syndrome lung carcinoma malignant glioma arthrogryposis muscle tissue disease breast cancer myopathy chronic kidney disease Crohn disease ovarian cancer dilated cardiomyopathy pancreatic intraductal papillary-mucinous neoplasm ductal breast carcinoma in situ reducing body myopathy head and neck cancer subependymal giant cell astrocytoma invasive ductal breast carcinoma lung adenocarcinoma malignant colon neoplasm malignant mesothelioma astrocytic tumor muscular disease breast carcinoma chronic obstructive pulmonary disease non-small cell lung carcinoma cystic fibrosis pancreatic ductal adenocarcinoma distal myopathy pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.